Chronic kidney disease: open trials in Spain

45 open trials have a site in Spain. Registry data; only the trial team decides who can take part.

NCT06742723
A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure
Trial Treatment · Phase 3 · AstraZeneca
Complexo Hospitalario Universitario A Coruña, A Coruña · Hospital Universitario Torrecárdenas, Almería · Hospital Germans Trias i Pujol, Badalona · Bellvitge University Hospital, L'hospitalet De Llobregat · Hospital Universitario Puerta de Hierro de Majadahonda, Majadahonda · Hospital Universitario Virgen de la Victoria, Málaga · University Hospital Son Espases, Palma · Clínica Universidad de navarra, Pamplona · University Hospital Virgen Del Rocio S.L., Sevilla · Hospital Universitario Virgen De La Macarena, Sevilla · Hospital Clinico Universitario de Valencia, Valencia · Hospital Universitario Dr. Peset Aleixandre, Valencia
Registry updated 2026-11-06
NCT07348484
Urinary Biomarker-Based Diagnostic and Monitoring System for Chronic Kidney Disease and Real-World Effectiveness of SGLT2 Inhibitors
Research · Instituto de Investigación Biomédica de Salamanca
Hospital Universitario De Salamanca, Salamanca
Registry updated 2026-11-05
NCT07241390
A Study of Orforglipron (LY3502970) on Cardiovascular Outcomes in Adults With Atherosclerotic Cardiovascular Disease and/or Chronic Kidney Disease (ATTAIN-Outcomes)
Trial Treatment · Phase 3 · Eli Lilly and Company
Hospital Universitario de La Ribera, Alzira · Centro Periférico de Especialidades Bola Azul, Andalucia · Hospital Universitario de Badajoz, Badajoz · Hospital Germans Trias i Pujol, Badalona · Hospital Universitari Vall d'Hebron, Barcelona · Hospital Universitario HM Monteprincipe, Boadilla del Monte · Hospital Polusa S.A., Lugo · Hospital Universitario Puerta de Hierro de Majadahonda, Majadahonda · University Hospital Son Espases, Palma · Hospital Universitario Marqués de Valdecilla, Santander · University Hospital Virgen Del Rocio S.L., Sevilla · Hospital Quironsalud Infanta Luisa, Sevilla · Hospital Alta Resolución De Utrera, Utrera Andalucia · Hospital Clínico de Valencia, Valencia · Hospital Universitario Dr. Peset Aleixandre, Valencia · Hospital Clínico Universitario de Valladolid, Valladolid
Registry updated 2026-11-04
NCT06823115
Assessment of Worldwide Acute Kidney Injury Epidemiology in Neonates 2.0
Research · Indiana University
Puerta del Mar University Hospital, Cadiz
Registry updated 2026-10-28
NCT06593392
Safety and Tolerability of Difelikefalin in Adolescents on Haemodialysis With Moderate-to-Severe Pruritus
Trial Treatment · Phase 2 · Vifor Fresenius Medical Care Renal Pharma
Hospital Sant Joan de Déu, Barcelona · Hospital Universitario Valle de Hebrón, Barcelona · La Paz University Hospital, Madrid
Registry updated 2026-10-23
2026-526938-23-00
Efficacy and safety of Grafalon® versus Thymoglobulin® for induction therapy in kidney transplant recipients at high risk of delayed graft function: a phase IV randomized open-label study
Trial Treatment · Phase 4 · Fundacion Para El Fomento De La Investigacion Sanitaria Y Biomedica De La Comunitat Valenciana
Hospital Universitario Dr. Peset Aleixandre, Valencia
Registry updated 2026-10-19
2023-507449-27-01
CKD-bioMatch: A biomarker-targeted clinical trial to optimize treatment for patients with chronic kidney disease
Trial Treatment · Phase 4 · Steno Diabetes Center Copenhagen
Hospital Clínico de Valencia, Valencia
Registry updated 2026-10-14
NCT07554469
An Observational Study, Called FINEXPLORER, to Learn More About How Well Finerenone Works in Adults in Spain With Chronic Kidney Disease (CKD) Linked to Type 2 Diabetes, by Looking at Changes in a CKD Risk Score
Research · Bayer
Many Locations, Many Locations
Registry updated 2026-10-14
NCT04557462
A Rollover Extension Program (REP) to Evaluate the Long-term Safety and Tolerability of Open Label Iptacopan/LNP023 in Participants With Primary IgA Nephropathy
Trial Treatment · Phase 3 · Novartis Pharmaceuticals
Hospital Clinic de Barcelona, Barcelona · Clínica Universidad de navarra, Pamplona · Hospital Universitario De Salamanca, Salamanca
Registry updated 2026-10-05
NCT06058585
The Chronic Kidney Disease Adaptive Platform Trial Investigating Various Agents for Therapeutic Effect
Trial Treatment · Phase 3 · The George Institute
Hospital Germans Trias i Pujol, Badalona · Hospital Universitario Vall d'Hebron, Barcelona · Hospital Universitari Arnau De Vilanova De La Gerencia Territorial De Lleida, Lleida · University Clinical Hospital Virgen De La Arrixaca, Murcia · Hospital Universitario Virgen Macarena, Sevilla · Hospital Universitario Dr. Peset Aleixandre, Valencia · Hospital Clínico de Valencia, Valencia · Hospital Universitario Y Politecnico La Fe, Valencia · Hospital Clinico Universitario Lozano Blesa, Zaragoza
Registry updated 2026-10-05
NCT05287945
Study of Orellanine in Metastatic Clear-Cell or Papillary Renal Cell Carcinoma
Trial Treatment · Phase 1/2 · Oncorena AB
Clinica Mi Nova Alianca, Lleida
Registry updated 2026-10-01
NCT07851454
Walnuts for Cardiorenal Protection in Adults With Chronic Kidney Disease
Trial Treatment · Institut Investigacio Sanitaria Pere Virgili
Unit for Public Health and Nutritional Epidemiology, Faculty of Medicine and Health Sciences, Universitat Rovira i Virgili, Reus
Registry updated 2026-10-01
NCT05457283
A Study to Learn More About How Safe the Study Treatment Finerenone is in Long-term Use When Taken With an ACE Inhibitor or Angiotensin Receptor Blocker Over 18 Months of Use in Children and Young Adults From 1 to 18 Years of Age With Chronic Kidney Disease and Proteinuria
Trial Treatment · Phase 3 · Bayer
Hospital Universitari Vall d'Hebron, Barcelona · Sant Joan De Deu Barcelona Hospital, Esplugues De Llobregat · Hospital Universitario 12 de Octubre, Madrid · Hospital Universitario La Paz, Madrid · Hospital Universitario Regional de Málaga, Málaga · University Hospital Virgen Del Rocio S.L., Sevilla
Registry updated 2026-09-24
NCT07624305
A Phase III Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With CKD Stage 3b and 4 (BalanceD-CKD)
Trial Treatment · Phase 3 · AstraZeneca
Badajoz · Barcelona · Córdoba · Girona · Madrid · Majadahonda · Talavera de la Reina · Valencia
Registry updated 2026-09-24
NCT05485961
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
Trial Treatment · Phase 2/3 · CSL Behring
Centro de dialisis Alcobendas, Alcobendas · Hospital Universitario Valle de Hebrón, Barcelona · Hospital Universitari de Bellvitge-IDIBELL, Barcelona · University Hospital Reina Sofia, Córdoba · Hospital Universitari de Girona Dr Josep Trueta, (Avitum), Girona · Hospital Universitario Virgen de las Nieves, Granada · Universidad de Alcala (UAH), Guadalajara · Hospital Universitari Arnau de Vilanova, Lleida · Hospital Clínico San Carlos, Madrid · Hospital Universitario Fundación Jiménez Díaz, Madrid · Hospital Universitario de la Princesa, Madrid · Universitario Gregorio Marañon, Madrid · Hospital Universitario Príncipe de Asturias, Madrid · Hospital de Manises, Manises · Hospital Universitari Son Espases, Palma de Mallorca · CHUS - H. Clinico U. de Santiago, Santiago de Compostela · Hospital Universitario Virgen de la Macarena, Seville · Fresenius Medical Care Centro de Diálisis Terrassa, Terrassa · Centro Hospital Universitario Dr. Preset, Valencia · Hospital Clinico Universitario Valencia, Valencia · Hospital Universitari i Politécnic La Fe, Valencia
Registry updated 2026-09-21
2025-522407-23-00
A Phase IIb study to evaluate the effect of combination of dapagliflozin and baxdrostat compared with baxdrostat alone in participants with chronic kidney disease and high blood pressure
Trial Treatment · Phase 2 · AstraZeneca AB
Hospital Germans Trias i Pujol, Badalona · Clinica Universidad de Navarra, Madrid · Clínica Universidad de navarra, Pamplona · Hospital Clinico Universitario de Valencia, Valencia
Registry updated 2026-09-17
NCT06578533
Keeping RAASi Treatment With Optimal Potassium Control
Trial Treatment · Phase 3 · Fundación para la Investigación del Hospital Clínico de Valencia
Hospital General Universitario Dr. Balmis, Alicante · Hospital Universitario Vall d'Hebron, Barcelona · Hospital Universitario 12 de Octubre, Madrid · Hospital Clinico Universitario de Valencia, Valencia · Hospital Universitario Doctor Peset, Valencia
Registry updated 2026-09-09
NCT07753993
A Study to Investigate Outcomes With Elecoglipron Compared With Placebo in Adult Participants With Chronic Kidney Disease.
Trial Treatment · Phase 3 · AstraZeneca
Hospital Universitario de Badajoz, Badajoz · Hospital Clinic de Barcelona, Barcelona · Hospital Universitari Vall d'Hebron, Barcelona · Hospital Universitario De Burgos, Burgos · Hospital Universitario Reina Sofia, Córdoba · Hospital Universitario Virgen de las Nieves, Granada · Hospital Universitario 12 de Octubre, Madrid · Hospital Universitario Puerta de Hierro de Majadahonda, Majadahonda · Hospital Universitario Virgen de la Victoria, Málaga · Hospital Universitario de Navarra, Pamplona · Hospital Universitario Y Politecnico La Fe, Valencia · Hospital Clinico Universitario de Valencia, Valencia
Registry updated 2026-09-09
NCT07662135
A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus and Impaired Renal Function on Background Dapagliflozin
Trial Treatment · Phase 3 · AstraZeneca
Hospital Universitari Vall d'Hebron, Barcelona · Hospital Nisa Sevilla Aljarafe, Castilleja De La Cuesta · Area Sanitaria De Ferrol, Ferrol · Hospital Universitari Arnau De Vilanova De La Gerencia Territorial De Lleida, Lleida · Hospital Universitario Fundación Jiménez Díaz, Madrid · Hospital Universitario Puerta de Hierro de Majadahonda, Majadahonda · Hospital Universitario Virgen de la Victoria, Málaga · Hospital Universitario Marqués de Valdecilla, Santander · Hospital Quironsalud Infanta Luisa, Sevilla · University Hospital Virgen Del Rocio S.L., Sevilla · Hospital Clinico Universitario de Valencia, Valencia · Hospital Clinico Universitario Lozano Blesa, Zaragoza
Registry updated 2026-09-02
NCT03969329
A Phase 3 Study of Etelcalcetide in Children With Secondary Hyperparathyroidism Receiving Hemodialysis
Trial Treatment · Phase 3 · Amgen
Hospital Universitari Vall d'Hebron, Barcelona · University Hospital Virgen Del Rocio S.L., Sevilla
Registry updated 2026-08-21
NCT05753930
Imlifidase Prior to Kidney Transplant in Highly Sensitised Children
Trial Treatment · Phase 2 · Hansa Biopharma AB
Hospital Sant Joan de Déu Barcelona, Barcelona · Hospital Unviersitari Vall d'Hebron, Nefrología Pediátrica, Barcelona
Registry updated 2026-08-18
NCT07701382
Remote vs In-Person Prehabilitation for Kidney Transplant Candidates
Trial Treatment · Hospital Clinic of Barcelona
Hospital Clinic Barcelona, Barcelona
Registry updated 2026-07-14
NCT07642778
Reference Values for Lower-Limb Dynamometry in Patients With Chronic Kidney Disease (REHAD-CKD)
Research · Cardenal Herrera University
Diaverum Madrid, Madrid
Registry updated 2026-06-12
NCT07607197
Immunological Reset to Enable Access to Hla-compatible Kidney Transplantation in Highly Sensitized Patients (RESET)
Trial Treatment · Phase 1/2 · Hospital Universitari Vall d'Hebron Research Institute
Fir Huvh Fundacio Institut De Recerca Hospital Universitari Vall De Hebron, Barcelona
Registry updated 2026-06-04
2025-525068-13-00
Albuminuria Reduction Trial and Investigation with Survodutide Treatment in CKD (ARTIST-CKD)
Trial Treatment · Phase 2 · Universitair Medisch Centrum Groningen
Hospital Germans Trias i Pujol, Badalona · Hospital Universitari Vall d'Hebron, Barcelona · Bellvitge University Hospital, L'hospitalet De Llobregat · Hospital Polusa S.A., Lugo · Hospital Universitario de la Princesa, Madrid · Hospital Universitario Fundación Jiménez Díaz, Madrid · Hospital Universitario Puerta de Hierro de Majadahonda, Majadahonda · Hospital Universitario de Navarra, Pamplona · Nuevas Tecnologias En Diabetes Y En Endocrinologia S.L. Profesional, Sevilla · Hospital Clinico Universitario de Valencia, Valencia
Registry updated 2026-05-19

All Chronic kidney disease trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error